Cyteir Therapeutics, Inc. Quarterly Current Ratio in % from Q1 2022 to Q3 2023

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Cyteir Therapeutics, Inc. quarterly Current Ratio history and growth rate from Q1 2022 to Q3 2023.
  • Cyteir Therapeutics, Inc. Current Ratio for the quarter ending September 30, 2023 was 2.53K %, a 11.8% increase year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2023 2.53K +267 +11.8% Sep 30, 2023
Q2 2023 2.67K +384 +16.8% Jun 30, 2023
Q1 2023 2.6K +144 +5.85% Mar 31, 2023
Q4 2022 2.28K Dec 31, 2022
Q3 2022 2.26K Sep 30, 2022
Q2 2022 2.29K Jun 30, 2022
Q1 2022 2.46K Mar 31, 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.